RxDoctor Payments Data

Elise Payne, NP

Acute Care · Apex, NCNPI 1700458742

Payments from drug & device makers

$1,368in general payments, 2019–2025

Across 75 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$153
  • Otsuka America Pharmaceutical, Inc.$110
  • Novo Nordisk$105
  • GSK$81
  • Boehringer Ingelheim$77
  • Dynavax Technologies Corporation$71
  • plus $770 from 25 others

What the payments were for

  • Food & beverage$1,368100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,368 in reported general payments places this provider in the 80th percentile of 312 acute care providers in North Carolina.

See all acute care providers in North Carolina

Medicare billing

Part B allowed, 2024
$22,752
Medicare patients
90
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$74,522
JardianceEmpagliflozin52$46,969
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$43,517
MounjaroTirzepatide27$40,011
FarxigaDapagliflozin Propanediol47$38,798
EliquisApixaban31$22,081
TrulicityDulaglutide11$22,042
Rosuvastatin Calcium311$4,419
Atorvastatin Calcium289$3,877
SymbicortBudesonide/Formoterol Fumarate17$3,776
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$3,469
Albuterol Sulfate HfaAlbuterol Sulfate119$3,207
Omeprazole177$3,193
Fluoxetine Hcl58$2,450
Gabapentin163$2,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$105$74,52255 claims
Lilly USA, LLCMounjaro, Trulicity$58$62,05238 claims
Boehringer IngelheimJardiance$77$46,96952 claims
GSKTrelegy Ellipta$81$43,51730 claims
AstraZenecaFarxiga, Symbicort$60$42,57464 claims
PfizerEliquis$47$22,08131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 312 acute care providers in North Carolina.

Other acute care in Apex

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →